Congratulations to Womble Bond Dickinson client SHL Medical. On July 18, the Switzerland-based life sciences company announced it was establishing new operations in North Charleston, S.C. The project will bring approximately 165 new jobs to the region, as well as a $90 million investment.
A Womble Bond Dickinson team led by Stephanie Yarbrough and including Cordes Ford, Andrew Hogue and Jennifer Cory provided economic development counsel to SHL Medical for this project, including state and local incentives. The new facility is expected to start operations by Q2 2024.
SHL Medical designs, develops and manufactures drug delivery solutions for pharmaceutical and biotech companies around the world. Some of the company’s products include autoinjectors and pen injectors, allowing patients to administer their needed medications at home.
In a statement, SHL Medical Chairman and CEO Ulrich Faessler said, “I am delighted to announce SHL’s expansion into South Carolina. Our new U.S. site in North Charleston will be a state-of-the-art facility that will support our customers further with our end-to-end capabilities, providing high-quality drug delivery systems to the end users – patients around the world. This new facility brings us closer to our customers and reduces the risk of supply chain disturbances. Furthermore, it will support our sustainability goals by lessening global shipping distances. I want to acknowledge the support that we have received from the state and county levels for this project.”